What is the address of CABINET SOINS INFIRMIERS GHARBI?

The registered office of CABINET SOINS INFIRMIERS GHARBI is located at Rue de Ragnies(ST) 4, 6511 Beaumont.

Is CABINET SOINS INFIRMIERS GHARBI still active?

Yes. According to the CBE (27 September 2026) CABINET SOINS INFIRMIERS GHARBI is active, legal situation “Normale toestand”, started on 24 March 1993.

Is CABINET SOINS INFIRMIERS GHARBI registered on Peppol?

Yes, CABINET SOINS INFIRMIERS GHARBI is registered on the Peppol network with ID 0208:0449837401.

What is the enterprise number of CABINET SOINS INFIRMIERS GHARBI?

The enterprise number of CABINET SOINS INFIRMIERS GHARBI is BE0449837401.

When was CABINET SOINS INFIRMIERS GHARBI founded?

CABINET SOINS INFIRMIERS GHARBI was founded on 24 March 1993.

Who are the directors of CABINET SOINS INFIRMIERS GHARBI?

According to the 2025 annual accounts, the directors of CABINET SOINS INFIRMIERS GHARBI are: Naziha Gharbi.

Is CABINET SOINS INFIRMIERS GHARBI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 March 1993; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CABINET SOINS INFIRMIERS GHARBI make in 2025?

CABINET SOINS INFIRMIERS GHARBI posted a profit after taxes of € 21,382 in financial year 2025.

What is the revenue of CABINET SOINS INFIRMIERS GHARBI?

As a small company, CABINET SOINS INFIRMIERS GHARBI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 40,256.

CABINET SOINS INFIRMIERS GHARBI (Private Limited)

Dossier CABINET SOINS INFIRMIERS GHARBI, printed on 27 September 2026 from databakkes.be/en/0449837401/cabinet-soins-infirmiers-gharbi. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2023.

Financials

Financial year 2025

CABINET SOINS INFIRMIERS GHARBI from Beaumont, company number BE0449837401, closed financial year 2025 with a result of € 21,382 after tax. For that financial year CABINET SOINS INFIRMIERS GHARBI recorded a gross margin of € 40,256 and equity of € 49,029. Compared with financial year 2024, the result moved from € 17,618 to € 21,382. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 3, 2026.

What it is worth Growing

€ 49,029

▲ 42% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 21,382

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,243

▲ 132% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 7,000 paid out

33 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 8,841

▼ 53% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 7,741

▼ 54% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,555

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,350

▼ 17% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 21,980 Gross margin 2022: € 21,980 First fiscal year in the series	€ 22,868 Gross margin 2023: € 22,868 ▲ 4% vs 2022 (€ 21,980) Favourable step	€ 34,193 Gross margin 2024: € 34,193 ▲ 50% vs 2023 (€ 22,868) Favourable step	€ 40,256 Gross margin 2025: € 40,256 ▲ 18% vs 2024 (€ 34,193) Favourable step	▲ 18%
Profit after taxes	€ 7,470 Profit after taxes 2022: € 7,470 First fiscal year in the series	€ 10,029 Profit after taxes 2023: € 10,029 ▲ 34% vs 2022 (€ 7,470) Favourable step	€ 17,618 Profit after taxes 2024: € 17,618 ▲ 76% vs 2023 (€ 10,029) Favourable step	€ 21,382 Profit after taxes 2025: € 21,382 ▲ 21% vs 2024 (€ 17,618) Favourable step	▲ 21%
Equity	€ 62,055 Equity 2022: € 62,055 First fiscal year in the series	€ 72,084 Equity 2023: € 72,084 ▲ 16% vs 2022 (€ 62,055) Favourable step	€ 34,647 Equity 2024: € 34,647 ▼ 52% vs 2023 (€ 72,084) Unfavourable step	€ 49,029 Equity 2025: € 49,029 ▲ 42% vs 2024 (€ 34,647) Favourable step	▲ 42%
Total debts	€ 47,301 Total debts 2022: € 47,301 First fiscal year in the series	€ 37,505 Total debts 2023: € 37,505 ▼ 21% vs 2022 (€ 47,301) Favourable step	€ 46,336 Total debts 2024: € 46,336 ▲ 24% vs 2023 (€ 37,505) Unfavourable step	€ 38,191 Total debts 2025: € 38,191 ▼ 18% vs 2024 (€ 46,336) Favourable step	▼ 18%
Cash	€ 1,999 Cash 2022: € 1,999 First fiscal year in the series	€ 5,405 Cash 2023: € 5,405 ▲ 170% vs 2022 (€ 1,999) Favourable step	€ 4,413 Cash 2024: € 4,413 ▼ 18% vs 2023 (€ 5,405) Unfavourable step	€ 10,243 Cash 2025: € 10,243 ▲ 132% vs 2024 (€ 4,413) Favourable step	▲ 132%
Retained profit	€ 43,463 Retained profit 2022: € 43,463 First fiscal year in the series	€ 53,492 Retained profit 2023: € 53,492 ▲ 23% vs 2022 (€ 43,463) Favourable step	€ 34,647 Retained profit 2024: € 34,647 ▼ 35% vs 2023 (€ 53,492) Unfavourable step	€ 49,029 Retained profit 2025: € 49,029 ▲ 42% vs 2024 (€ 34,647) Favourable step	▲ 42%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 36,463 Dividend 2024: € 36,463 Unchanged (€ 0) Unchanged	€ 7,000 Dividend 2025: € 7,000 ▼ 81% vs 2024 (€ 36,463) Unchanged	▼ 81%
Bank debt	€ 34,504 Bank debt 2022: € 34,504 First fiscal year in the series	€ 25,752 Bank debt 2023: € 25,752 ▼ 25% vs 2022 (€ 34,504) Favourable step	€ 16,826 Bank debt 2024: € 16,826 ▼ 35% vs 2023 (€ 25,752) Favourable step	€ 7,741 Bank debt 2025: € 7,741 ▼ 54% vs 2024 (€ 16,826) Favourable step	▼ 54%
Balance sheet total	€ 109,356 Balance sheet total 2022: € 109,356 First fiscal year in the series	€ 109,589 Balance sheet total 2023: € 109,589 Unchanged (€ 109,356) Unchanged	€ 80,983 Balance sheet total 2024: € 80,983 ▼ 26% vs 2023 (€ 109,589) Unchanged	€ 87,220 Balance sheet total 2025: € 87,220 ▲ 8% vs 2024 (€ 80,983) Unchanged	▲ 8%

Key figures of CABINET SOINS INFIRMIERS GHARBI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CABINET SOINS INFIRMIERS GHARBI?

What happened at CABINET SOINS INFIRMIERS GHARBI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 3, 2026 New annual accounts for financial year 2025: profit of € 21,382 (▲ 21% vs 2024). filed late Source: NBB ↗
Apr 27, 1993 New establishment in Beaumont. KBO
Mar 24, 1993 Start of the company according to the CBE. KBO

In short

From € 7,470 profit in 2022 to € 21,382 profit in 2025.

Paid € 30,121 in corporate taxes since 2022.

Best year ever: 2025, with € 21,382 profit.

Paid out € 43,463 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CABINET SOINS INFIRMIERS GHARBI? We notify you, reason included.

Follow CABINET SOINS INFIRMIERS GHARBI

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Naziha Gharbi

CABINET SOINS INFIRMIERS GHARBI

Behind CABINET SOINS INFIRMIERS GHARBI is Naziha Gharbi.

See the full network in the app

Directors

According to the 2025 annual accounts

Naziha Gharbi

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Ragnies(ST) 4

6511 Beaumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0449.837.401
VAT number: BE 0449.837.401
Registered office: Rue de Ragnies(ST) 4, 6511 Beaumont
Names & denominations: CABINET SOINS INFIRMIERS GHARBI
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 March 1993
Peppol: Active · Active since 7 Apr 2026

View on CBE Public ↗ Annual accounts (NBB) ↗